4.7 Review

The ex vivo human lung: research value for translational science

期刊

JCI INSIGHT
卷 4, 期 11, 页码 -

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/jci.insight.128833

关键词

-

资金

  1. NIH [T32DK007573-23, HL135849, HL126176, HL126456, HL140026, HL134828]
  2. Societe Francaise d'Anesthesie-Reanimation (Paris, France)
  3. Journees Rennaises d'Anesthesie-Reanimation association (Rennes, France)
  4. National Heart, Lung, and Blood Institute [HL113022]
  5. UCSF Nina Ireland Program for Lung Health
  6. Association Chirurgicale pour le Developpement et l'Amelioration des Techniques de Depistage de Traitement des Maladies Cardiovasculaires (Paris, France)

向作者/读者索取更多资源

Respiratory diseases are among the leading causes of death and disability worldwide. However, the pathogenesis of both acute and chronic lung diseases remains incompletely understood. As a result, therapeutic options for important clinical problems, including acute respiratory distress syndrome and chronic obstructive pulmonary disease, are limited. Research efforts have been held back in part by the difficulty of modeling lung injury in animals. Donor human lungs that have been rejected for transplantation offer a valuable alternative for understanding these diseases. In 2007, our group developed a simple preparation of an ex vivo-perfused single human lung. In this Review, we discuss the availability of donor human lungs for research, describe the ex vivo-perfused lung preparation, and highlight how this preparation can be used to study the mechanisms of lung injury, to isolate primary cells, and to test novel therapeutics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据